O-Selectivity and Utility of Phosphorylation
A R T I C L E S
Table 2. Reaction Cycle for the Synthesis of Oligodeoxyribonucleotides by Use of ABI 392 DNA Synthesizer
step
operation
reagent(s)
time, min
1
2
3
4
5
6
7
8
washing
detritylation
washing
coupling
coupling
washing
oxidation
washing
CH3CN
3% Cl3CCOOH/CH2Cl2
CH3CN
0.2
1.5
0.4
1.0
1.0
0.2
0.5
0.4
tf
0.1 M amidite + 0.2 M HO Bt in CH3CN-NMP (15:1, v/v)
tf
0.1 M amidite + 0.2 M HO Bt in CH3CN-NMP (15:1, v/v)
CH3CN
0.1 M I2 in Py-H2O-THF (v/v/v)
CH3CN
and deoxyguanosine-O-3′-phosphoramidite derivatives were synthesized
by the method reported by Gryaznov and Letsinger.
Ab Initio Calculations. All ab initio molecular orbital calculations
were carried out using the Gaussian 94 program on a Cray C-916/
steps: (1) detritylation (3% trichloroacetic acid in CH
min); (2) washing [CH Cl CN (1 mL × 3)]; (3) the
(1 mL × 3), CH
first coupling [an appropriate phosphoramidite unit (10 µmol) in
CH CN-NMP (150 µL, 9:1, v/v), HOBt (6.3 mg, 20 µmol) in CH CN-
NMP (150 µL, 9:1, v/v), 1 min]; (4) washing [CH
CN (1 mL × 3)];
(5) the second coupling [an appropriate phosphoramidite unit (10 µmol)
in CH CN-NMP (150 µL, 9:1, v/v), HOBt (6.3 mg, 20 µmol) in CH
CN-NMP (150 µL, 9:1, v/v), 1 min]; (6) washing [CH
CN (1 mL ×
3)]; (7) oxidation [0.1 M I , pyridine-H O (9/1, v/v), 2 min]; and (8)
Cl
2 2
Cl , 2 mL, 1
1
0
2
2
3
3
3
1
2256 supercomputer. Geometry optimizations were carried out at the
3
HF/6-31G* level and single-point energy calculations were carried out
at the MP2/6-31G* level involving electronic correlation to obtain
accurate energies and atomic charges.
Synthesis of the N-Unprotected d[TpA] Derivative. A mixture of
the thymidine 3′-O-phosphoramidite derivative 4 (267 mg, 0.36 mmol)
and 3′-O-(tert-butyldimethylsilyl)deoxyadenosine 5 (109 mg, 0.3 mmol)
was rendered anhydrous by repeated coevaporation successively with
3
3
-
3
2
2
washing [pyridine (1 mL × 3), CH
3
CN (1 mL × 3), CH
2
2
(1 mL ×
3)]. Generally, the average yield per cycle was estimated to be 98-
99% by the DMTr cation assay. After chain elongation was finished,
the DMTr group was removed by treatment with 3% trichloroacetic
dry pyridine (×3), dry toluene (×3), and dry CH
dissolved in dry CH CN (5 mL). To the mixture was added HOBt (97
mg, 0.72 mmol). After the mixture was stirred at room temperature
for 5 min, a 1 M solution of I in pyridine-water (9:1, v/v, 3 mL) was
added to the mixture. After being stirred at room temperature for 2
min, the mixture was partitioned between CHCl (50 mL) and aqueous
% Na (30 mL). The organic phase was collected, washed twice
with aqueous 5% Na (30 mL), filtered, dried over Na SO , and
2
Cl
2
(×3), and finally
3
acid in CH
(1 mL × 3) and CH
and released from the polymer support by treatment with concentrated
NH aq (500 µL) for 40 min or 12 h. The polymer support was removed
by filtration and washed with CH
Cl
2 2
(2 mL) for 1 min, and the resin was washed with CH
2 2
Cl
3
CN (1 mL × 3). The oligomer was deprotected
2
3
3
3
CN (1 mL × 3). The filtrate was
5
2
S O
2 3
evaporated and purified by reversed-phase HPLC or anion-exchange
HPLC.
S
2 2
O
3
2
4
evaporated under reduced pressure. The residue was chromatographed
on a column of silica gel (10 g) with 1% pyridine containing hexane-
On the other hand, in synthesis of the dimers d[ApT], d[CpT], and
[GpT] by use of the phosphoramidite units 14a,c,g having a methyl
group as the protecting group of the phosphate group, the DMTr group
CHCl
3
(50:50-0:100, v/v) and then 1% pyridine containing CHCl -
3
MeOH (100:0-97:3, v/v) to give the fractions containing 7. To remove
the last traces of pyridine, the fractions were collected, evaporated under
reduced pressure, and finally evaporated by repeated coevaporation three
was removed by treatment with 3% trichloroacetic acid in CH
mL) for 1 min, and the resin was washed with CH Cl
(1 mL × 3) and
CH
group was deprotected by treatment with the solution of thiophenol-
triethylamine-dioxane (1:1:2, v/v/v, 400 µL) for 1 h at room temper-
2 2
Cl (2
2
2
3
CN (1 mL × 3) after chain elongation was finished. The methyl
1
times each with toluene and CH
NMR (CDCl
(
(
2
Cl
2
to give 7 (280 mg, 91%):
H
3
) δ 0.11 (s, 6H), 0.90 (s, 6H), 1.40 (s, 3H), 2.30-2.95
m, 6H), 3.28-3.47 (m, 2H), 3.76 (s, 6H), 4.01-4.30 (m, 6H), 4.73
d, 1H, J ) 2.4 Hz), 5.11 (s, 1H), 6.33-6.52 (m, 4H), 6.80 (dd, 4H, J
3.0 Hz, J ) 9.0 Hz), 7.23-7.33 (m, 9H), 8.02 (d, 1H, J ) 2.7 Hz),
ature, and the resin was washed with CH
(1 mL × 3). The oligomer was deprotected and released from the
polymer support by treatment with concentrated NH aq (500 µL) for
40 min or 12 h. The polymer support was removed by filtration and
washed with CH
2
Cl
2
(1 mL × 3) and CH
3
CN
)
3
3
1
13
8
.36 (d, 1H, J ) 4.59 Hz); P NMR (CDCl
3
) δ -2.19, -1.84;
C
3
NMR (CDCl ) δ -4.7, -4.5, 11.7, 11.8, 17.9, 19.1, 19.4, 19.5, 19.6,
3
CN (1 mL × 3). The filtrate was evaporated and
2
7
1
1
1
1
5.7, 39.8, 39.9, 55.2, 62.0, 62.1, 62.3, 63.1, 71.5, 71.7, 77.2, 79.1,
purified by reversed-phase HPLC or anion-exchange HPLC.
B. Synthesis of Phosphorothioate Thymidine Dimer Tp(s)T 15.
A thymidine-loaded HCP (1 µmol, 28 µmol/g, succinate linker) was
used. Each cycle of chain elongation consisted of the following steps:
9.4, 83.8, 83.9, 84.2, 84.4, 85.1, 86.9, 87.0, 111.4, 111.5, 113.2, 115.9,
16.2, 119.4, 119.6, 125.1, 127.0, 127.8, 128.0, 128.1, 128.9, 129.9,
34.9, 139.3, 139.5, 143.8, 143.9, 148.9, 151.1, 151.3, 152.6, 155.7,
58.5, 164.5, 164.7. MS m/z calcd for M + H 1025.3994, found
025.3987.
(1) detritylation (3% trichloroacetic acid in CH
washing [CH Cl CN (1 mL × 3)]; (3) coupling
(1 mL × 3), CH
[thymidine phosphoramidite unit (14.8 mg, 20 µmol) in CH CN-NMP
(150 µL, 9:1, v/v), activator (20 µmol) in CH CN-NMP (150 µL, 9:1,
v/v), 1 min]; (4) washing [CH
CN (1 mL × 3)]; (5) sulfurization [0.2
M 3H-1,2-benzodithiol-3one-1,1-dioxaide, CH CN (400 µL), 2 min];
and (6) washing [pyridine (1 mL × 3), CH CN (1 mL × 3), CH Cl (1
mL × 3)]. After chain elongation was finished, the DMTr group was
removed by treatment with 3% trichloroacetic acid in CH Cl (2 mL)
for 1 min, and the resin was washed with CH Cl
(1 mL × 3) and
CH
CN (1 mL × 3). The oligomer was deprotected and released from
the polymer support by treatment with concentrated NH aq (500 mL)
for 40 min. The polymer support was removed by filtration and washed
with CH
2 2
Cl , 2 mL, 1 min); (2)
2
2
3
In a similar manner, the N-unprotected d[TpC] derivative 8 was
3
1
synthesized: H NMR (CDCl
3
) δ -0.01 (s, 6H), 0.86 (s, 9H), 1.29 (s,
3
3
9
1
1
9
H), 2.11-2.71 (m, 6H), 3.33 (d, 1H, J ) 8.6 Hz), 3.45 (d, 1H, J )
3
.7 Hz), 3.67 (s, 6H), 3.92 (s, 1H), 4.13-4.23 (m, 5H), 5.10-5.22 (m,
H), 5.92 (dd, 1H, J ) 7.1 Hz, J ) 17.6 Hz), 6.15 (m, 1H), 6.36 (dd,
H, J ) 5.1 Hz, J ) 8.9 Hz), 6.77 (d, 4H, J ) 8.9 Hz), 7.23-7.33 (m,
3
3
2
2
31
H), 7.47 (s, 1H), 7.61 (dd, 1H, J ) 4.3 Hz, J ) 7.3 Hz); P NMR
2
2
1
3
(CDCl
3
) δ -1.67, -1.58; C NMR (CDCl
3
) δ -4.8, -4.6, 11.8, 17.9,
2
2
1
7
1
1
9.6, 19.7, 19.8, 25.7, 39.0, 41.2, 55.3, 62.5, 62.6, 63.3, 70.0, 70.4,
7.2, 79.9, 84.2, 84.4, 86.1, 94.9, 111.8, 113.2, 116.2, 116.4, 123.6,
27.1, 127.9, 128.0, 128.9, 129.9, 134.8, 134.9, 135.8, 140.3, 143.8,
49.6, 150.6, 150.7, 155.3, 158.6, 163.7, 163.8, 165.5. MS m/z calcd
3
3
3
CN (1 mL × 3). The filtrate was evaporated and purified by
for M + H 1001.3882, found 1001.3876.
reversed-phase HPLC.
Typical Procedure for Solid-Phase Synthesis. A. Manual Opera-
tion. A thymidine-loaded HCP (1 µmol, 28 µmol/g, succinate linker)
was used. Each cycle of chain elongation consisted of the following
C. Automated Operation. The synthesis of oligodeoxyribonucle-
otides by use of ABI 392 DNA synthesizer was carried out according
to the reaction cycle shown in Table 2. In the synthesis of d(CAGT)
3
,
J. AM. CHEM. SOC. VOL. 126, NO. 35, 2004 10895
9